Analyst Michael Morabito works at CHARDAN CAPITAL and is covering the Healthcare, Industrials sectors with 38 price targets and ratings documented since 2019 spanning on 8 stocks.
Michael Morabito's average stock forecast success ratio is 36.11% with an average time for price targets to be met of 157.17 days.
Most recent stock forecast was given on AXLA, Axcella Health Inc at 02-Nov-2022.
Analyst best performing recommendations are on MRTX (MIRATI THERAPEUTICS, INC).
The best stock recommendation documented was for MRTX (MIRATI THERAPEUTICS, INC) at 8/7/2020. The price target of $140 was fulfilled within 10 days with a profit of $11.12 (8.63%) receiving and performance score of 8.63.
Average potential price target upside
Currently, out of the existing stock ratings of Michael Morabito - 4 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
44
$37.98 (630.90%)
60
13 days ago
0/2 (0%)
$40.5 (484.59%)
Buy
32
$25.98 (431.56%)
21 days ago
0/1 (0%)
$27.38 (592.64%)
Buy
80
$73.98 (1228.90%)
80
2 years 25 days ago
0/6 (0%)
$55.23 (290.00%)
Buy
80
$73.98 (1228.90%)
70
2 years 3 months 28 days ago
0/3 (0%)
$48.13 (220.91%)
Buy
50
$43.98 (730.56%)
2 years 9 months 26 days ago
0/5 (0%)
$26.32 (113.47%)
